Yahoo Finance Trade Alert: The Non-Executive Director Of Medical Developments International Limited (ASX:MVP), Christine Emmanuel, Has Just Spent AU$100k Buying A Few More Shares
Whilst it may not be a huge deal, we thought it was good to see that the Medical Developments International Limited (ASX:MVP) Non-Executive Director, Christine Emmanuel, recently bought AU$100k worth of stock, for AU$6.50 per share. Nevertheless, it only increased their shareholding by a minuscule percentage, and it wasn't a massive purchase by absolute value, either.
See our latest analysis for Medical Developments International
Medical Developments International Insider Transactions Over The Last Year
The Non-Executive Chairman Gordon Naylor made the biggest insider purchase in the last 12 months. That single transaction was for AU$1.0m worth of shares at a price of AU$3.89 each. Even though the purchase was made at a significantly lower price than the recent price (AU$4.88), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.
Happily, we note that in the last year insiders paid AU$2.9m for 579.73k shares. But they sold 154.00k shares for AU$1.0m. Overall, Medical Developments International insiders were net buyers during the last year. The average buy price was around AU$4.98. I'd consider this a positive as it suggests insiders see value at around the current price. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.
Insider Ownership
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. Medical Developments International insiders own about AU$61m worth of shares. That equates to 17% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
So What Do The Medical Developments International Insider Transactions Indicate?
The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Given that insiders also own a fair bit of Medical Developments International we think they are probably pretty confident of a bright future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Medical Developments International. To assist with this, we've discovered 2 warning signs that you should run your eye over to get a better picture of Medical Developments International.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
